Диссертация (1174276), страница 24

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 24)

Stolz, A. Meyer, J. Rakic, et al. // Eur. Respir. J. – 2014. – Vol. 44, N. 6. – Р. 15571570.182. Supino, P.G. Acceptability and psychometric properties of the MinnesotaLiving with Heart Failure Questionnaire among patients undergoing heart valve surgeryvalidation and comparison with SF-36 / P.G. Supino, J.S. Borer, J.A. Franciosa, et al. //J. Card. Failure. – 2009. – Vol.15. – P. 267-277.183. Terzano, C. Atrial fibrillation in the acute, hypercapnic exacerbations ofCOPD / C.

Terzano, S. Romani, V. Conti, et al. // Eur. Rev. Med. Pharmacol. Sci. –2014. – Vol. 19. – P. 2908-2917.152184. Testa, G. Chronic obstructive pulmonary disease and long-term mortality inelderly subjects with chronic heart failure / G. Testa, F. Cacciatore, A.

Bianco, et al. //Aging Clin. Exp. Res. – 2017. – Vol. 29, N. 6. – Р. 1157-1164.185. Testa, G. Role of permanent atrial fibrillation (AF) on long-term mortality incommunity-dwelling elderly people with and without chronic heart failure (CHF) / G.Testa, F. Cacciatore, D. Della-Morte, et al. // Arch. Gerontol. Geriatr. – 2012. – Vol. 55.– Р. 91-95.186. Triposkiadis, F. Global left atrial failure in heart failure / F. Triposkiadis, B.Pieske, J.

Butler, J. Parissis // Eur. J. Heart Fail. – 2016. – Vol. 18. – Р. 1307-1320.187. Ukena, C. The cardiopulmonary continuum systemic inflammation as'common soil' of heart and lung disease / C. Ukena, F. Mahfoud, M. Kindermann, et al.// Int.

J. Cardiol. – 2010. – Vol. 145. – Р. 172-176.188. Vestbo, J. Changes in forced expiratory volume in 1 s over time in COPD /J. Vestbo, L.D. Edwards, P.D. Scanlon, et al. // N. Engl. J. Med. – 2011. – Vol. 365. –Р. 1184-1192.189. Vestbo, J. Should we view chronic obstructive pulmonary disease differentlyafter ECLIPSE? A clinical perspective from the study team / J. Vestbo, A.

Agusti, E.F.Wouters, et al. // J Respir Crit Care Med. Am – 2014. – Vol. 189, N. 9. – Р. 1022-1030.190. Vodovar, N. Elevated Plasma B-Type Natriuretic Peptide ConcentrationsDirectly Inhibit Circulating Neprilysin Activity in Heart Failure / N. Vodovar, M. F.Séronde, S. Laribi, et al. // JACC Heart Fail. – 2015. – Vol. 3, N. 8. – Р. 629-636.191.Vogelmeier, C.F. Global Strategy for the Diagnosis, Management, andPrevention of Chronic Obstructive Lung Disease 2017 Report.

GOLD ExecutiveSummary. / C.F. Vogelmeier, G.J. Griner, E.F. Martinez, et al. // Am. J. Respir. CritCare Med. – 2017. - Vol. 195, N. 5. – P. 557-582.192. Winkler, C. Comprehensive characterisation of pulmonary and serumsurfactant protein D in COPD / C. Winkler, E.N. Atochina-Vasserman, O. Holz1, et al.// Respiratory Research. – 2011.

– Vol. 12. – Р. 29.153193. Yo, C.H. Value of high-sensitivity C-reactive protein assays in predictingatrial fibrillation recurrence: a systematic review and meta-analysis / C.H. Yo, S.H. Lee,S.S. Chang, et al. // BMJ. – 2014. – Vol. 20. – Р. 4.194. Zafrir, B. Prognostic implications of atrial fibrillation in heart failure withreduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in theEuropean Society of Cardiology Heart Failure Long-Term Registry. / B.

Zafrir, L.H.Lund, C. Laroche, et al. // Eur Heart J. – 2018. – N. 39(48). – Р. 4277-4284.195. Zemans, R.L. Multiple biomarkers predict disease severity, progression andmortality in COPD / R.L. Zemans, S. Jacobson, J. Keene, et al. // RespiratoryResearch.– 2017. – Vol. 18, N. 1. – Р.

117.196. Zoni-Berisso, М. Epidemiology of atrial fibrillation: European perspective /М. Zoni-Berisso, F. Lercari, T. Carazza, S. Domenicucci // Clin. Epidemiol. – 2014. –Vol. 6. – Р. 213–220..

Характеристики

Список файлов диссертации